{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "authorship_tag": "ABX9TyNL5uGQrybVShgZxQ4MX7IA"
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "source": [
        "# **A/B Test: Free Trial Length (7-day vs 14-day)**\n",
        "\n",
        "**Primary question:** Does giving users more time to experience the product increase paid conversion and lifetime value?\n",
        "\n",
        "**Objective:** Determine whether a 14-day free trial (Variant B) produces higher paid conversion and better LTV than a 7-day free trial (Variant A), without substantially worsening acquisition quality or increasing abuse.\n",
        "\n",
        "# **Success metrics & definitions**\n",
        "\n",
        "**Primary metrics:**\n",
        "\n",
        "•\t**Paid conversion rate (PCR)** — (# users who convert to paid within X days after trial start) / (# users who started trial)\n",
        "\n",
        "•\t**Customer lifetime value (LTV)** — mean present-value of revenue per user over the chosen observation window (e.g., 180 days).\n",
        "\n",
        "**Metric windows:**\n",
        "\n",
        "•\t**Paid conversion window**: 30 days and 90 days post-trial start (report both)\n",
        "\n",
        "•\t**LTV observation window**: 90 days\n",
        "\n",
        "# **Variants**\n",
        "\n",
        "•\t**Control (A)**: 7-day free trial\n",
        "\n",
        "•\t**Treatment (B)**: 14-day free trial\n",
        "\n",
        "# **Target population & eligibility**\n",
        "\n",
        "•\t**Universe**: New users (first-time accounts) who reach the trial offer.\n",
        "\n",
        "•\t**Inclusion criteria**: Users who are eligible for the free trial (not on trial cooldown, not previously converted)\n",
        "\n",
        "•\t**Exclusion criteri**: Internal QA, employees, test accounts, users from geos with legal restrictions\n",
        "\n",
        "# **Randomization & allocation**\n",
        "\n",
        "•\t**Unit of randomization**: User account ID\n",
        "\n",
        "•\t**Allocation**: 50/50 split (A:B)\n",
        "\n",
        "•\t**Randomization method**: Deterministic hash of user_id mod 100 -> <50 => A else B.\n",
        "\n",
        "# **Sample size & duration**\n",
        "\n",
        "•\t**Minimum detectable effect (MDE)**: choose meaningful uplift to detect. Example: target 10% relative uplift in paid conversion.\n",
        "\n",
        "**Duration guidance** At least one full paid-conversion window (30 days) has elapsed for earliest cohort. If N would take >4 weeks, ensure business seasonality is considered.\n",
        "\n",
        "# **Experiment instrumentation & data collection**\n",
        "\n",
        "**Event definitions:**\n",
        "\n",
        "•\t**trial_activated** — user clicks CTA and trial begins (record plan_id, trial_length_days)\n",
        "\n",
        "•\t**converted_to_paid** — billing success event, record plan, price, coupon_id\n",
        "\n",
        "# **Analysis (using Normal/Wald CI)**\n",
        "\n",
        "**Raw counts:**\n",
        "\n",
        "•\t**Variant A (7-day)**: total users = 244, activated = 165.\n",
        "\n",
        "•\t**Variant B (14-day)**: total users = 256, activated = 188.\n",
        "\n",
        "**Activation rate (proportion) for each varia**:\n",
        "\n",
        "**Variant A**\n",
        "\n",
        "•\tactivation_rate_A = activated_A / total_A = 165 / 244 = 0.6762\n",
        "\n",
        "**So Activation Rate (A) ≈ 67.62%.**\n",
        "\n",
        "**Variant B**\n",
        "\n",
        "•\tactivation_rate_B = activated_B / total_B = 188 / 256 = 0.734375\n",
        "\n",
        "**So Activation Rate (B) ≈ 73.44%.**\n",
        "\n",
        "**Absolute and relative differences**:\n",
        "\n",
        "•\t**Absolute difference (B − A)** = 0.734375 − 0.6762 ≈ 5.81 percentage points\n",
        "\n",
        "•\t**Relative uplift** = (absolute difference) / activation_rate_A = 0.0581 / 0.6762 ≈ 8.60% relative increase.\n",
        "\n",
        "**So Variant B has ~+5.8 pp absolute and ~+8.6% relative activation improvement over A in this synthetic sample.**\n",
        "\n",
        "**Primary analysis:**\n",
        "\n",
        "•\tCompare PCR between Variant B and Variant A using two-sided z-test for proportions (or Chi-square). Report absolute difference, relative percent change, 95% CI, and p-value.\n",
        "\n",
        "**Uncertainty on each activation rate (95% confidence intervals)**\n",
        "\n",
        "•\tSample proportions follow a **Normal distribution** (approximately) when sample size is large.\n",
        "\n",
        "•\t**Standard error** for a proportion p with n observations: SE = sqrt( p(1−p) / n )\n",
        "\n",
        "•\tA **95% confidence interval** corresponds to capturing the central 95% of a Normal distribution.\n",
        "\n",
        "•\tIn a standard Normal distribution, the values that cut off the middle 95% lie at ±1.96 standard deviations from the mean.\n",
        "\n",
        "**Variant A standard error:**\n",
        "\n",
        "•\tp = 0.6762, n = 244\n",
        "\n",
        "•\tSE_A = sqrt(0.6762295 × (1 − 0.6762) / 244) = 0.0299551\n",
        "\n",
        "**95% CI = p ± 1.96 × SE**\n",
        "\n",
        "•\tLower = 0.6762 − 1.96×0.0299551 = 0.6175\n",
        "\n",
        "•\tUpper = 0.6762 + 1.96×0.0299551 = 0.7349\n",
        "\n",
        "**So Activation Rate A 95% CI ≈ [61.75%, 73.49%].**\n",
        "\n",
        "**Variant B standard error:**\n",
        "\n",
        "•\tp = 0.734375, n = 256\n",
        "\n",
        "•\tSE_B = sqrt(0.734375 × (1 − 0.734375) / 256) = 0.0276\n",
        "\n",
        "**95% CI = p ± 1.96 × SE**\n",
        "\n",
        "•\tLower = 0.734375 − 1.96×0.0276 = 0.6803\n",
        "\n",
        "•\tUpper = 0.734375 + 1.96×0.0276 = 0.7885\n",
        "\n",
        "**So Activation Rate B 95% CI ≈ [68.03%, 78.85%].**\n",
        "\n",
        "# **Simple statistical test: two-proportion z-test (are activation rates significantly different?)**\n",
        "\n",
        "We test **H₀: p_A = p_B vs H₁: p_A ≠ p_B** using the pooled standard error.\n",
        "\n",
        "Steps:\n",
        "\n",
        "1.\t**Pooled proportion:** p_pool = (activated_A + activated_B) / (n_A + n_B) = (165 + 188) / (244 + 256) = 353 / 500 = 0.706\n",
        "2.\t**Standard error (pooled)**: SE_pool = sqrt( p_pool × (1 − p_pool) × (1/n_A + 1/n_B) ) = sqrt(0.706 × 0.294 × (1/244 + 1/256)) ≈ 0.040781\n",
        "3.\t**z statistic**: z = (p_B − p_A) / SE_pool = 0.0581454918 / 0.040781 ≈ 1.42649\n",
        "4.\t**two-sided p-value**: p = 2 × (1 − Φ(|z|)) → using standard normal CDF p ≈ 0.1537\n",
        "\n",
        "**Interpretation:** p ≈ 0.154 > 0.05, so we do not reject the null at the 5% level. In this synthetic sample, the observed activation uplift (≈5.8 pp) is **not statistically significant** at α = 0.05.\n",
        "\n",
        "# **Decision criteria**\n",
        "•\t**Declare Variant B winner if**: paid conversion is statistically significantly higher and LTV is equal or higher (or show business-significant improvement even if p>0.05 but CI excludes negative practical differences).\n",
        "\n",
        "•\t**Declare Variant A (control) winner if**: paid conversion is significantly higher for A, or Variant B increases abuse/refund rates materially.\n",
        "\n",
        "•\t**Tie / Inconclusive:** If paid conversion delta is not significant and LTV differences are small/uncertain, maintain current (7-day) and consider qualitative research.\n",
        "\n",
        "# **Risks & mitigations**\n",
        "\n",
        "•\t**Selection of low-quality users** — track downstream retention and refund rates; consider trial gating if abuse spikes.\n",
        "\n",
        "•\t**Seasonality & external campaigns** — ensure randomization is balanced across acquisition channels and campaign periods.\n",
        "\n",
        "•\t**Delayed cash flow** — track conversion timing to understand revenue lag.\n",
        "\n",
        "# **Notes and Insights**\n",
        "\n",
        "•\twith more users (larger n) the same absolute uplift could reach statistical significance.\n",
        "\n",
        "•\tIf B wins, roll out 14-day trial to 100% with monitoring for 30 days of conversion and refund signals.\n",
        "\n",
        "•\t**using Normal/Wald CI, result is inconclusive, so keep 7-day but run qualitative user interviews and consider testing targeted longer trials for specific segments.**"
      ],
      "metadata": {
        "id": "OFA_xmX5__3T"
      }
    }
  ]
}
